|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 289.48 USD | +3.14% |
|
+4.35% | +5.18% |
Company Valuation: Cigna
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 76,106 | 101,304 | 87,625 | 76,809 | 73,521 | 76,577 | - | - |
| Change | - | 33.11% | -13.5% | -12.34% | -4.28% | 4.16% | - | - |
| Enterprise Value (EV) 1 | 104,695 | 126,473 | 110,733 | 101,231 | 97,308 | 95,250 | 92,549 | 85,468 |
| Change | - | 20.8% | -12.45% | -8.58% | -3.88% | -2.11% | -2.84% | -7.65% |
| P/E ratio | 14.6x | 15.6x | 17.2x | 22.8x | 12.4x | 11.4x | 9.96x | 9.11x |
| PBR | 1.57x | 2.21x | 1.89x | 1.84x | 1.74x | 1.72x | 1.58x | 1.44x |
| PEG | - | 0.4x | -0.9x | -0.8x | 0.1x | 0.8x | 0.7x | 0.97x |
| Capitalization / Revenue | 0.44x | 0.56x | 0.45x | 0.31x | 0.27x | 0.27x | 0.26x | 0.25x |
| EV / Revenue | 0.6x | 0.7x | 0.57x | 0.41x | 0.35x | 0.33x | 0.31x | 0.27x |
| EV / EBITDA | 9.42x | 11x | 9.24x | 8.38x | 7.88x | 7.17x | 6.43x | 5.69x |
| EV / EBIT | 13.2x | 15x | 13x | 10.7x | 10.6x | 9.65x | 8.45x | 7.69x |
| EV / FCF | 17.3x | 17.2x | 10.8x | 11.3x | - | 10.5x | 9.16x | 8.45x |
| FCF Yield | 5.77% | 5.82% | 9.25% | 8.85% | - | 9.49% | 10.9% | 11.8% |
| Dividend per Share 2 | 4 | 4.48 | 4.92 | 5.6 | - | 6.178 | 6.447 | 6.75 |
| Rate of return | 1.74% | 1.35% | 1.64% | 2.03% | - | 2.13% | 2.23% | 2.33% |
| EPS 2 | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | 25.28 | 29.05 | 31.78 |
| Distribution rate | 25.4% | 21% | 28.3% | 46.2% | - | 24.4% | 22.2% | 21.2% |
| Net sales 1 | 174,078 | 180,642 | 195,322 | 247,099 | 274,900 | 284,479 | 297,074 | 312,309 |
| EBITDA 1 | 11,118 | 11,522 | 11,980 | 12,083 | 12,351 | 13,286 | 14,391 | 15,020 |
| EBIT 1 | 7,935 | 8,414 | 8,536 | 9,417 | 9,200 | 9,871 | 10,954 | 11,115 |
| Net income 1 | 5,365 | 6,668 | 5,164 | 3,434 | 5,957 | 6,597 | 7,699 | 7,782 |
| Net Debt 1 | 28,589 | 25,169 | 23,108 | 24,422 | 23,787 | 18,674 | 15,973 | 8,891 |
| Reference price 2 | 229.63 | 331.34 | 299.45 | 276.14 | 275.23 | 289.48 | 289.48 | 289.48 |
| Nbr of stocks (in thousands) | 331,428 | 305,739 | 292,620 | 278,153 | 267,126 | 264,532 | - | - |
| Announcement Date | 03/02/22 | 03/02/23 | 02/02/24 | 30/01/25 | 05/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.45x | 0.33x | 7.17x | 2.13% | 76.58B | ||
| 23.32x | 0.92x | 14.49x | 2.22% | 363B | ||
| 20.3x | 0.59x | 11.45x | 1.67% | 90.24B | ||
| 42.93x | 0.31x | 18.27x | 1.02% | 42.03B | ||
| 24.76x | 0.14x | 13.41x | -.--% | 30.78B | ||
| 55.04x | 0.19x | 12.67x | -.--% | 9.94B | ||
| 80.34x | 0.53x | 17.71x | -.--% | 3.18B | ||
| 19.94x | 1.34x | 7.79x | -.--% | 2.03B | ||
| 291.7x | 0.64x | 31.79x | -.--% | 2.02B | ||
| 48.28x | 2.71x | 14.3x | 0.57% | 280M | ||
| Average | 61.81x | 0.77x | 14.91x | 0.76% | 61.98B | |
| Weighted average by Cap. | 24.49x | 0.71x | 13.37x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CI Stock
- Valuation Cigna
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















